Methods: A systematic literature review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Three electronic databases (Pubmed, Embase (OVID) and Cochrane CENTRAL) were queried. All patients who underwent MSAP flaps with the following outcomes of interest were included: flap failure/success, flap/vessel dimensions, and complications. Descriptive analysis was performed on pooled flap characteristics. Effect size (z-values), odds ratios (ORs) and heterogeneity scores (Q and I2 statistics) were calculated for meta-analysis when possible. Multivariate logistic regression was performed to identify factors associated with increased complication rates.
Results:
Thirty-five studies encompassing 526 MSAP flaps were included for analysis. The most common reasons for surgery were oncologic (47.6%) and traumatic injuries (31.8%). The oral cavity was the most common recipient location (45.5%). Average flap dimensions were 6.0 ± 2.3cm by 9.8 ± 3.6cm with an average pedicle length of 10.1 ± 6.6cm. Meta-analysis revealed an overall complication rate of 14.3% (Q value=22.16, p=0.877, I2= -39.9). Use of chimeric MSAP flaps was associated with significantly higher rates of complications (OR=3.92, p=0.039, 95% CI 1.10-13.89). The majority of flap donor sites were closed primarily (68%) versus 32% that were covered with a split-thickness skin graft (STSG). A flap width greater than 5.75cm had an OR=5.3 (95% CI, 1.3-21.8; p=0.014) of having a donor site complication if closed primarily.
Donor site complication rate was 1.9% (n=10) overall. Out of 247 MSAP flaps, 68% were closed primarily versus 32% covered with a split-thickness skin graft (STSG). Average dimensions for flaps whose donor site was closed with a STSG (8.0cm by 12.2cm) was significantly greater than those closed primarily (5.0cm by 8.9cm, p<0.0001). Among those that underwent primary closure, a flap width greater than 5.75cm had an OR=5.3 (95% CI, 1.3-21.8; p=0.014) of having a donor site complication. There was no significant difference in donor site complications based on patient gender or use of primary closure versus STSG.
Conclusions: This is the first systematic literature review and meta-analysis demonstrating the efficacy and safety of the MSAP flap. Our results emphasize the utility of the MSAP flap as a potential workhorse flap for various recipient sites requiring thin, pliable tissue and a relatively long pedicle. With a favorable donor site that can be closed primarily in a flap width of nearly 6cm, the potential benefits of this flap cannot be understated.